PTPN11 and Noonan syndrome: Stat3 was aberrantly suppressed in peripheral blood cells from Noonan syndrome patients with gain-of-function Shp2 mutations, while Stat3 activation was significantly attenuated by activated Shp2 in bone marrow cells [35].